About Alvéole
Alvéole is a company based in Paris (France) founded in 2010. It operates as a Direct-to-Consumer (D2C). Alvéole has raised $1.16 million across 2 funding rounds from investors including Le Village by CA and Le Quattrocento. Alvéole offers products and services including PRIMO, LEONARDO, PLPP, and PDMS Stencil. Alvéole operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.16 M (USD)
in 2 rounds
-
Latest Funding Round
$1.16 M (USD), Seed
Oct 16, 2018
-
Investors
Le Village by CA
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alvéole
Alvéole offers a comprehensive portfolio of products and services, including PRIMO, LEONARDO, PLPP, and PDMS Stencil. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Bioengineering tool for creating smart cell culture substrates.
Software for enhancing bioengineering and micropatterning processes.
Reagent used in bioengineering for cell culture applications.
Tool for structuring hydrogels in cell biology research.
Funding Insights of Alvéole
Alvéole has successfully raised a total of $1.16M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.16 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.2M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2018 | Amount | Seed - Alvéole | Valuation | Quattrocento |
|
| Jul, 2018 | Amount | Seed - Alvéole | Valuation | Le Village by CA |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alvéole
Alvéole has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Le Village by CA and Le Quattrocento. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated sector-agnostically by Le Village by CA.
|
Founded Year | Domain | Location | |
|
Promising academic inventions are developed into life science startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alvéole
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alvéole
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alvéole Comparisons
Competitors of Alvéole
Alvéole operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Alvéole
When was Alvéole founded?
Alvéole was founded in 2010 and raised its 1st funding round 8 years after it was founded.
Where is Alvéole located?
Alvéole is headquartered in Paris, France.
Who is the current CEO of Alvéole?
Romuald Vally is the current CEO of Alvéole.
Is Alvéole a funded company?
Alvéole is a funded company, having raised a total of $1.16M across 2 funding rounds to date.
What does Alvéole do?
Alvéole is engaged in the development of bioengineering tools aimed at accelerating cell biology research. The company offers a range of products, including PRIMO for micropatterning and smart cell culture substrates, alongside complementary tools like LEONARDO software and PDMS stencils. Solutions provided by Alvéole are utilized by academic laboratories to enhance reliability and reproducibility in cell models. The focus is placed on user needs, ensuring innovations are tailored to practical research applications within the biotechnology sector.
Who are the top competitors of Alvéole?
Alvéole's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Alvéole offer?
Alvéole offers PRIMO, LEONARDO, PLPP, and PDMS Stencil.
Who are Alvéole's investors?
Alvéole has 2 investors. Key investors include Le Village by CA, and Le Quattrocento.